Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced (Unresectable) or Metastatic Solid Tumors

Explore clinical trials studying Locally Advanced (Unresectable) or Metastatic Solid Tumors. Study availability and eligibility vary by location and protocol.

4 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced (Unresectable) or Metastatic Solid Tumors trial results

Recruiting

A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid Tumors

NCT07612189

Conditions
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • NEXT Oncology Austin, Texas, United States
  • NEXT Oncology Dallas, Texas, United States
View Trial Details
Recruiting

A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

NCT07612176

Conditions
Locally Advanced (Unresectable) or Metastatic Solid Tumors, Neoplasm Metastasis, Neoplasms, +3 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • NEXT Oncology Austin, Texas, United States
  • NEXT Oncology Dallas, Texas, United States
View Trial Details
Recruiting

A Study of TXN10128 in Subjects With Solid Tumors

NCT05978492

Conditions
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Locations
  • Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea
  • Chungbuk National University Hospital Cheonju, North Chungcheong, South Korea
  • Seoul National Univ. Hospital Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
View Trial Details

Related conditions